# Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome

> **NCT02015598** · NA · COMPLETED · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 40 (actual)

## Conditions studied

- Obstructive Sleep Apnoea

## Interventions

- **DRUG:** Carbocysteine
- **DEVICE:** Continuous Positive Airway Pressure

## Key facts

- **NCT ID:** NCT02015598
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015598, "Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02015598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*